Pasithea Therapeutics Corp.
Ticker: 1841330
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY2022 | Q2 FY2022 | Q1 FY2022 | Q1 FY2022 |
|---|---|---|---|---|
| INCOME | ||||
| Revenue | 0.22+2100.0% | 0.01+0.0% | 0.01+0.0% | 0.01 |
| Total Income | 0.22+2100.0% | 0.01+0.0% | 0.01+0.0% | 0.01 |
| EXPENSES | ||||
| Expenditure | 4.47+44.7% | 3.09+27.7% | 2.42+15.8% | 2.09 |
| PROFIT | ||||
| PBT | -4.59-72.6% | -2.66-69.4% | -1.57-21.7% | -1.29 |
| Net Profit | -4.59-72.6% | -2.66-69.4% | -1.57+0.0% | -1.57 |
| KEY METRICS | ||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.17-54.5% | -0.11-57.1% | -0.07-600.0% | -0.01 |
Corporate Events
Board MeetingKTTA
20261May
Board Meeting
Chief Medical Officer Appointment — Kartik Krishnan appointe…
SEC Filing ↗